When providers compare EMS Swiss DolorClast radial pressure wave technology with electrohydraulic focused shockwave systems like StemWave, the question isn’t “Which device is better?”
It’s which technology is built for the types of conditions you treat.
These devices operate on fundamentally different physics. That difference determines:
How deep therapeutic energy reaches
What tissue structures can be treated
How protocols are structured
What clinical outcomes are realistic
How the service integrates into a practice
1. The Real Technology Divide: How Waves Are Generated
Radial Pressure Waves (EMS Swiss DolorClast)
DolorClast uses a ballistic radial pressure wave mechanism, patented by EMS in 1997.
How it works:
Compressed air accelerates a projectile inside the handpiece. The projectile hits a fixed applicator, producing mechanical pressure waves that spread outward from the skin surface.
Wave characteristics:
Highest energy at the skin surface
Energy disperses rapidly with depth
Most meaningful therapeutic effect occurs within ~1–3 cm
Measured acoustic penetration is roughly 3–4 cm, depending on tissue and settings
Longer rise times and lower peak pressures than focused shockwaves
This is why EMS refers to the output as radial pressure pulses—they are widely used, clinically valuable for the right indications, but they do not meet the strict physical criteria of a classic focused shockwave.
Electrohydraulic Focused Shockwaves
Electrohydraulic is the original form of extracorporeal shockwave generation.
How it works:
An electrical spark creates a plasma bubble in water. As the bubble expands and collapses, it generates a high-pressure acoustic pulse. A reflector focuses this pulse into a defined focal zone at depth.
Wave characteristics:
Propagation in tissue at ~1,500 m/s (4–5× faster than sound in air)
Very rapid pressure rise (on the order of a few–tens of nanoseconds)
Peak pressures that can reach the tens–hundreds of MPa range
A broad therapeutic focal zone spanning several centimeters
Energy converges at depth rather than dispersing at the surface
Electrohydraulic systems are known for having the widest focal zones and deepest energy penetration among focused shockwave technologies.
2. Depth: The Deciding Factor for Most Clinical Indications
Radial Pressure Wave Depth (DolorClast)
Radial waves deliver the majority of their therapeutic energy within the first 1–3 cm and exhibit measurable penetration around 3–4 cm. Beyond that, energy density declines quickly.
This depth range aligns with superficial tendons, fascia, and myofascial trigger points.
Electrohydraulic Shockwave Depth (StemWave)
Electrohydraulic systems can deliver focused energy to 10–12 cm, depending on settings and patient anatomy.
Because the energy converges at depth, the therapeutic dose is not lost as tissue layers increase.
What this means clinically:
Radial = reliable for surface-level pathology
Focused = capable of treating both superficial and deep structures with one device
Depth alone explains why focused shockwave is commonly used in cases involving the shoulder, hip, spine, or deep knee—regions simply outside radial’s effective range.
3. Focal Zone Size: Why Coverage Pattern Matters
Radial Pressure Waves
Coverage is broad at the skin surface but loses force with depth.
This makes radial excellent for:
Superficial myofascial pain
Broad trigger-point regions
Surface tendinopathies
Electrohydraulic Focused Shockwaves
Electrohydraulic devices create a large, structured focal zone—often several centimeters wide—allowing providers to treat an entire pathological region (not just a pinpoint).
This is especially important because most degenerative conditions (rotator cuff, hip labrum, meniscal degeneration) are multi-centimeter, multilayer problems rather than single-spot lesions.
4. What Each Technology Treats Best
Best-Fit Conditions for Radial Pressure Waves (DolorClast)
These conditions sit comfortably within radial’s 3–4 cm reach:
Plantar fasciitis
Achilles tendinopathy (insertional)
Patellar tendinopathy
Medial tibial stress syndrome
Greater trochanteric pain syndrome (bursal origin)
Tennis elbow, golfer’s elbow
Superficial trigger points and myofascial restrictions
Where radial excels: high-volume, surface-level musculoskeletal cases.
Best-Fit Conditions for Electrohydraulic Focused Shockwaves
Focused shockwave covers all radial indications plus deep or complex pathology:
Deep rotator cuff tendinopathy and impingement
Hip labral irritation and deep gluteal syndrome
Iliopsoas, deep hamstring, and proximal adductor pathology
Sacroiliac joint dysfunction
Lumbar facet irritation and deep spinal ligament involvement
Meniscal degeneration and knee OA
Post-surgical adhesions affecting deeper layers
Chronic pelvic and posterior hip pain
If the target tissue is deeper than 3–4 cm, focused shockwave becomes the appropriate modality.
5. Treatment Protocol Differences
Radial Protocols (DolorClast)
2,000–3,000 pulses per area
15–25 Hz
3–5 sessions, 1–2× weekly
Minimum 72 hours between sessions
Applicator is moved continuously for broad coverage
This works well for superficial, surface-spread pathology.
Focused Electrohydraulic Protocols (StemWave)
300–500 pulses per area
8–12 total sessions, typically twice weekly early on
Focal zone enables targeted, depth-specific dosing
Providers rely on patient feedback, acoustic changes, and palpation to locate dysfunctional tissue layers
Because energy is delivered efficiently at depth, fewer pulses are required.
6. Practice Integration: Where Each System Makes Sense
Radial Shockwave Fits Best In:
Podiatry
High-volume sports medicine
PT clinics focused on superficial tendinopathies
Practices prioritizing lower-cost, high-throughput treatments
Radial systems tend to carry a lower capital cost and command modest cash rates ($75–150 per session).
Electrohydraulic Focused Shockwave Fits Best In:
Multi-specialty MSK clinics
Chiropractors treating beyond the spine
Orthopedic and sports medicine practices
Regenerative medicine and chronic pain settings
Clinics seeking a single device capable of treating both surface and deep pathology
Due to its versatility and depth capabilities, focused shockwave often supports premium treatment plans ($1,500–2,500 per protocol) and broader patient applicability.
7. Support, Training, and Implementation
EMS Swiss DolorClast
Swiss DolorClast Academy (theoretical + practical training)
Device certification and practice finder listings
Protocol app with 17 indications in multiple languages
Strong research portfolio, including numerous RCTs using DolorClast radial devices
StemWave
Comprehensive clinical onboarding covering 50+ conditions
Large provider community (750+ active users)
Weekly clinical coaching and case-review calls
Protocols plus marketing and patient-education systems to help integrate the service line
Business support for patient acquisition, conversion, and outcomes tracking
Both companies invest heavily in training; the difference is that StemWave’s model includes full practice-integration infrastructure beyond clinical technique.
8. Bottom Line: Which Should a Provider Choose?
Both technologies are clinically valid.
They are simply not designed for the same job.
Choose Radial If:
Your practice primarily treats superficial tendinopathies and myofascial pain and you want a lower-cost, high-volume treatment option.
Choose Focused Electrohydraulic If:
You need to treat a wide spectrum of MSK conditions—including deep, layered, or complex pathology—with one device and want a system that supports premium service-line development.
The real decision comes down to this:
Does your patient population require treatment beyond the first 3–4 cm of tissue?
If the answer is yes, focused shockwave becomes essential.
Learn More About StemWave
If your clinic treats a mix of chronic, complex, and deep musculoskeletal conditions, explore how electrohydraulic focused shockwave may better align with your clinical and business goals by clicking the button below.
Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are those of medical professionals and are based on a collective analysis of publicly available studies and data. Our company’s product is a Class I medical device, and while it may be related to the topics discussed in this post, it is important to note that our product may not cause similar effects as stated in the post. Additionally, this post should not be interpreted as a guarantee of any specific outcome or result. It’s important to consult with a qualified healthcare professional for personalized medical advice and treatment. We encourage readers to consult the FDA’s website for information on our product’s clearance and any relevant labeling information.